Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Net Cash Flow (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Net Cash Flow for 16 consecutive years, with $19.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow fell 64.49% year-over-year to $19.2 million, compared with a TTM value of -$2.0 million through Dec 2025, down 104.16%, and an annual FY2025 reading of -$2.0 million, down 104.16% over the prior year.
  • Net Cash Flow was $19.2 million for Q4 2025 at Orthofix Medical, up from -$2.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $54.1 million in Q4 2024 and bottomed at -$25.8 million in Q1 2025.
  • Average Net Cash Flow over 5 years is -$549450.0, with a median of -$1.6 million recorded in 2021.
  • The sharpest move saw Net Cash Flow crashed 1169.02% in 2022, then skyrocketed 1516.57% in 2025.
  • Year by year, Net Cash Flow stood at $4.8 million in 2021, then plummeted by 142.36% to -$2.1 million in 2022, then skyrocketed by 272.01% to $3.5 million in 2023, then soared by 1430.77% to $54.1 million in 2024, then plummeted by 64.49% to $19.2 million in 2025.
  • Business Quant data shows Net Cash Flow for OFIX at $19.2 million in Q4 2025, -$2.6 million in Q3 2025, and $7.2 million in Q2 2025.